"MicroGenDX is Introducing PerioDX, the First Commercially Available Saliva-Based qPCR+NGS Test for Oral Health"

Head and Neck Cancers and the Oral Microbiome

  1. Hayes RB, Ahn J, Fan X, et al. Association of Oral Microbiome with Risk for Incident Head and Neck Squamous Cell Cancer. JAMA Oncol. 2018;4(3):358–365. doi:10.1001/jamaoncol.2017.4777
  2. Shin, J.M., Luo, T., Kamarajan, P. et al. Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma – A High Fusobacterial and Low Streptococcal Signature. Sci Rep 7, 9934 (2017).
  3. Vesty, Anna et al. “Microbial and inflammatory-based salivary biomarkers of head and neck squamous cell carcinoma.” Clinical and experimental dental research vol. 4,6 255-262. 28 Nov. 2018, doi:10.1002/cre2.139
  4. Chen Z, Wong PY, Ng CWK, Lan L, Fung S, Li JW, Cai L, Lei P, Mou Q, Wong SH, Wu WKK, Li RJ, Meehan K, Lui VWY, Chow C, Lo KW, Chan ABW, Boon SS, Lau EHL, Yeung Z, Chan KCA, Wong EWY, Cheng ASL, Yu J, Chan PKS, Chan JYK. The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma. Cancers. 2020; 12(11):3425; https://doi.org/10.3390/cancers12113425 https://www.mdpi.com/894398